SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.

Shenzhen Weiguang Biological Products Co., Ltd.

002880

CNE100002Q58

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 21/05/2024 BST			5-day change	1st Jan Change
30.29 ^CNY	-1.30%		-0.30%	-13.78%

04-26	Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for the Year 2023	CI
2023	Weiguang Biological Products Gets Registration Certificate for Human Coagulation Factor VIII Drug	MT

Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend on A Shares for the Year 2020, Payable on June 16, 2021

June 09, 2021 at 08:33 pm

Shenzhen Weiguang Biological Products Co., Ltd. proposed final cash dividend per ten shares (tax included) on A shares of CNY 2.50000000 for the year 2020, payable on June 16, 2021. Record date is June 15, 2021. Ex-date is June 16, 2021.

Latest news about Shenzhen Weiguang Biological Products Co., Ltd.

Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for the Year 2023	04-26	CI
Weiguang Biological Products Gets Registration Certificate for Human Coagulation Factor VIII Drug	11-06	MT
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemdented (A Shares) for 2023, Payable on 31 October 2023	24/10/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Interim Dividend for Year 2023	18/09/23	CI
Shenzhen Weiguang Biological Products Co., Ltd.(XSEC:002880) added to S&P Global BMI Index	18/09/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023	25/08/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23	CI
Weiguang Biological Products Halts Trading on Potential Change in Control	29/05/23	MT
Shenzhen Liying Biotechnology Co., Ltd announced that it has received funding from Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd. and other investors	23/05/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23	CI
Shenzhen Liying Biotechnology Co., Ltd announced that it has received funding from Goldport Capital, Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd. and other investors	05/04/23	CI
Weiguang Biological Products to Buy 80% of Plasma Collection Firm For 23 Million Yuan	10/01/23	MT
Shenzhen Weiguang Biological Products Co., Ltd. agreed to acquire 80% stake in Ankang Huitian Plasmapheresis Station Co., Ltd. from Xia Yuzhen for CNY 22.8 million	09/01/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	29/10/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Cash Dividend on A Shares for 2021, Payable on 8 July 2022	03/07/22	CI
Shenzhen Weiguang Biological Products Co., Ltd.(XSEC:002880) dropped from S&P Global BMI Index	20/06/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Approves Cash Dividend for the Year 2021	13/05/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for 2021	15/04/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/04/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. announced that it expects to receive CNY 1.15 billion in funding	08/03/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	18/08/21	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend on A Shares for the Year 2020, Payable on June 16, 2021	09/06/21	CI

Chart Shenzhen Weiguang Biological Products Co., Ltd.

Duration

Period

Chart Shenzhen Weiguang Biological Products Co., Ltd.

More charts

Company Profile

SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS Co., Ltd. is a China-based high-tech company principally engaged in the research and development, production and sales of biological products. The Companyâs primary products are blood products, including the human serum albumin, human immunoglobulin, intravenous human immunoglobulin, freeze-dried intravenous human immunoglobulin, hepatitis B human immunoglobulin, Rabies immunoglobulin, tetanus immunoglobulin, histamine human immunoglobulin, and human fibrinogen. The Company mainly operates its businesses in domestic market.

Sector

Pharmaceuticals

Calendar

15/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

30.29 CNY

Average target price

36 CNY

Spread / Average Target

+18.85%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.	-13.78%	949M
CSL LIMITED	-1.62%	89.22B
SAMSUNG BIOLOGICS CO.,LTD.	+2.24%	40.49B
BIOGEN INC.	-12.97%	32.79B
UCB	+61.79%	26.23B
BIOMARIN PHARMACEUTICAL INC.	-20.71%	14.52B
INCYTE CORPORATION	-7.31%	13.09B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.64%	11.5B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.60%	11.6B
SWEDISH ORPHAN BIOVITRUM AB	+4.27%	8.82B

Biopharmaceuticals